恆指倒跌近百點考驗28,500 美團急挫8.7%失守牛熊線 惟石油及醫藥股受捧
美國4月非農就業新增職位意外急速放緩至26.6萬個(前值增幅更大幅下修14.7萬個),遠少預期增加97.8萬個,緩解市場對通脹升溫令聯儲局提早「收水」擔憂,美股三大指數上周五升近0.7%-0.9%,道指及標普齊創紀錄高後,美股期貨全面續升不足0.3%。亞太區股市今早也普遍上升,尤其是4月NAB商業信心及景氣急升同創紀錄高的澳洲200續升1.1%曾見7,167逾十四個月高。
不過,港股先升後跌,其中恆指繼上周續累吐逾百點後,今早高開166點或0.6%報28,776,最高見28,842無以為繼,掉頭低見28,509,現造28,522,續跌88點或0.3%,成交額765億元。此外,恆科指數高開回升至8,045遇阻,掉頭倒跌0.8%,報7,890。
藍籌股榮辱互見,美團(03690.HK)延續上周弱勢,今早股價急挫8.7%報258.2元,失守牛熊線(265.6元)兼創逾半年低;海底撈(06862.HK)續跌3.7%曾低見40.6元創約廿一個月低。此外,中移動(00941.HK)及聯通(00762.HK)也跌逾1%,分別低見49.15元及4.47元。安踏(02020.HK)高開逾1%報146.2元欠承接,掉頭倒跌2.4%報140.8元,股價失守10天線(104.9元)。
相反,阿里健康(00241.HK)升3.7%報23.75元,股價一舉重越20天、10天及50天線(23.1-23.6元)。中生製藥(01177.HK)升逾3%曾高見8.42元;藥明生物(02269.HK)及石藥(01093.HK)升2.8%及2.4%,分別報104.7元及9.73元,股價分別重越百天線(102.65元)及10天線(9.63元);申洲(02313.HK)升2%報180.8元。此外,「三桶油」中石化(00386.HK)、中海油(00883.HK)及中石油(00857.HK)升近2%-3%。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.